XML 18 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net earnings $ 41,460,000 $ 34,559,000 $ 20,699,000
Adjustments to reconcile net earnings to net cash provided by operating activities:      
Provision for depreciation 3,531,000 4,372,000 2,765,000
Intangibles amortization 1,515,000 1,635,000 582,000
Deferred income tax (benefit) (4,528,000) (1,190,000) (2,311,000)
Provision for doubtful notes and credit losses (285,000) 285,000 0
(Gain) loss on disposal of property, plant and equipment (7,000) 463,000
Loss on impairment 0 0 5,295,000
Proceeds from insurance claim 0 0 151,000
Noncash retirement plan expense 904,000 863,000 803,000
Gain on bargain purchase 0 0 (492,000)
Gain on sale of subsidiary 0 (351,000) 0
Other 856,000 591,000 514,000
Accounts receivable, net (13,277,000) 20,337,000 (12,903,000)
Inventories (87,579,000) (38,627,000) (5,620,000)
Other assets and current assets 2,122,000 2,137,000 147,000
Accounts payable and accrued liabilities 390,000 18,288,000 (676,000)
Federal and state income taxes payable 1,465,000 2,497,000 (649,000)
Net cash provided by (used in) operating activities (53,426,000) 45,389,000 8,768,000
Cash flows from investing activities:      
Marketable securities purchased (5,432,000) (47,709,000) (20,024,000)
Marketable securities - maturities and sales 26,891,000 46,243,000 29,195,000
Purchase of property, plant and equipment (7,531,000) (1,840,000) (1,030,000)
Proceeds from notes receivable 1,037,000 627,000 106,000
Acquisition of businesses, net of cash acquired 0 0 (24,683,000)
Proceeds from sale of subsidiary 0 2,000,000 0
Proceeds from insurance claim 0 232,000 0
Net cash provided by (used in) investing activities 14,965,000 (447,000) (16,436,000)
Cash flows from financing activities:      
Proceeds from line of credit 8,000,000 0 0
Payments on line of credit (8,000,000) 0 0
Dividends paid (32,029,000) (28,385,000) (31,826,000)
Proceeds from sale of treasury stock 513,000 429,000 436,000
Other (17,000) (40,000) (36,000)
Net cash used in financing activities (31,533,000) (27,996,000) (31,426,000)
Net increase (decrease) in cash and cash equivalents (69,994,000) 16,946,000 (39,094,000)
Cash and cash equivalents at beginning of year 87,657,000 70,711,000 109,805,000
Cash and cash equivalents at end of year 17,663,000 87,657,000 70,711,000
Supplemental disclosures of cash flow information:      
Income taxes 11,963,000 6,843,000 8,208,000
Interest on line of credit $ 2,000 $ 0 $ 0